Oric Pharmaceuticals, Inc. (ORIC) Total Assets by Year
Oric Pharmaceuticals, Inc. closed fiscal year 2025 with $408.9M in total assets, $24.5M in total liabilities and $384.4M in shareholder equity. This represents an increase of 49.2% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Oric Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ORIC Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $408.9M+49.2% | $274.1M+8.8% | $252.0M+2.0% | $247.2M-17.2% | $298.6M-0.1% | $299.0M+217.8% | $94.1M | N/A |
| Total Liabilities | $24.5M-20.9% | $31.0M+11.1% | $27.9M+12.5% | $24.8M-3.3% | $25.7M+178.3% | $9.2M-95.0% | $184.2M | N/A |
| Total Equity | $384.4M+58.1% | $243.1M+8.5% | $224.1M+0.8% | $222.4M-18.5% | $273.0M-5.8% | $289.8M+421.7% | -$90.1M-39.8% | -$64.4M |
ORIC Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $404.7M+16.7% | $436.8M+79.8% | $408.9M+49.2% | $431.2M+42.7% | $346.9M+5.5% | $242.9M-30.8% | $274.1M+8.8% | $302.1M+10.1% | $328.9M+12.7% | $350.8M+54.8% | $252.0M+2.0% | $274.3M+15.3% |
| Total Liabilities | $23.4M+2.5% | $21.2M-8.3% | $24.5M-20.9% | $24.3M-13.5% | $22.9M-13.7% | $23.1M+4.4% | $31.0M+11.1% | $28.1M+4.3% | $26.5M+15.2% | $22.1M-7.1% | $27.9M+12.5% | $26.9M+16.1% |
| Total Equity | $381.3M+17.7% | $415.6M+89.1% | $384.4M+58.1% | $406.9M+48.5% | $324.0M+7.1% | $219.7M-33.1% | $243.1M+8.5% | $274.0M+10.7% | $302.4M+12.5% | $328.6M+62.0% | $224.1M+0.8% | $247.4M+15.2% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Oric Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was Oric Pharmaceuticals, Inc.'s total assets in fiscal year 2025?
Oric Pharmaceuticals, Inc. closed fiscal year 2025 with $408.9M in total assets, $24.5M in total liabilities and $384.4M in shareholder equity.
How fast is Oric Pharmaceuticals, Inc.'s total assets growing?
Oric Pharmaceuticals, Inc. (ORIC) total assets rose by 49.2% year over year, from $274.1M to $408.9M in fiscal year 2025.
What was Oric Pharmaceuticals, Inc.'s total assets in the most recent quarter?
Oric Pharmaceuticals, Inc. (ORIC) reported $404.7M in total assets in Q2 2026. This represents an increase of 16.7% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Oric Pharmaceuticals, Inc. (ORIC) reported on that line in every period on record.